0000000000246819

AUTHOR

R Wachter

showing 5 related works from this author

Abstract WP201: Stroke Patients With Atrial Fibrillation Detected by 72 hour- versus Prolonged ECG-monitoring

2018

Background: Detecting concealed paroxysmal atrial fibrillation (pAF) is a major focus in the workup of ischemic-stroke-patients. The minimal ECG-monitoring for stroke patients was recently expanded from 24 to 72 hours. However, it has been shown that even more prolonged monitoring reveals further pAF-cases. Our aim was to determine, whether known predictors for underlying pAF differ between stroke patients with AF that occurs on shorter (72h) or more prolonged ECG-monitoring (>72h). Methods: The Find-AF RANDOMISED -trial (NCT01855035) evaluated 3x10-day Holter-ECG vs. standard-care in patients > 60 years with acute ischemic strokes with the primary endpoint of novel pAF after 6 month…

Advanced and Specialized Nursingmedicine.medical_specialtyStroke patientmedicine.diagnostic_testbusiness.industrymedicine.drug_classParoxysmal atrial fibrillationAtrial fibrillation030204 cardiovascular system & hematologymedicine.diseaseEcg monitoring03 medical and health sciences0302 clinical medicineInternal medicinemedicineNatriuretic peptideCardiologycardiovascular diseasesNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessElectrocardiographyStroke030217 neurology & neurosurgeryStroke
researchProduct

Abstract 124: How to Preselect Stroke Patients for Enhanced ECG-Monitoring - Evaluation of Predictors of Paroxysmal Atrial Fibrillation in "Find-AFra…

2019

Background: Detecting concealed paroxysmal atrial fibrillation (pAF) is a major focus of the workup of ischemic-stroke-patients, but requires elaborate ECG-monitoring. We aimed to evaluate pre-specified predictors to determine stroke patients with an increased probability of underlying pAF. We applied cut-off-levels recently suggested by the German Stroke Society 1 . Methods: The Find-AF RANDOMISED -trial (NCT01855035) evaluated 3x10-day Holter-ECG vs. standard-care in 398 patients > 60 years with acute ischemic strokes. The primary endpoint was novel pAF after 6 months. 27 patients in the intervention arm (13.5 %) and 9 patients in the control arm (9.0 %) met the primary endpoint (p=0.…

Advanced and Specialized Nursingmedicine.medical_specialtymedicine.diagnostic_testStroke patientParoxysmal atrial fibrillationbusiness.industryAtrial fibrillation030204 cardiovascular system & hematologymedicine.diseaseEcg monitoring03 medical and health sciences0302 clinical medicineInternal medicinemedicineCardiologycardiovascular diseasesNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessElectrocardiography030217 neurology & neurosurgeryStroke
researchProduct

NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke

2019

Background and Purpose— Ischemic stroke causes major disability as a consequence of neuronal loss and recurrent ischemic events. Biomarkers predicting tissue damage or stroke recurrence might be useful to guide an individualized stroke therapy. NfL (neurofilament light chain) is a promising biomarker that might be used for this purpose. Methods— We used individual data of patients with an acute ischemic stroke and clinical long term follow-up. Serum NfL (sNfL) was quantified within 24 hours after admission and after 1 year and compared with other biomarkers (GDF15 [growth differentiation factor 15], S100, NT-proBNP [N-terminal pro-B-type natriuretic peptide], ANP [atrial natriuretic peptid…

Advanced and Specialized Nursing0303 health sciencesmedicine.medical_specialtybusiness.industrymedicine.drug_classOdds ratiomedicine.disease3. Good healthBrain ischemia03 medical and health sciences0302 clinical medicineInterquartile rangeModified Rankin ScaleInternal medicineDiabetes mellitusClinical endpointmedicineNatriuretic peptideCardiologyNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessStroke030217 neurology & neurosurgery030304 developmental biologyStroke
researchProduct

Quality of Life 3 and 12 Months Following Acute Pulmonary Embolism

2021

BACKGROUND Few data are available on the long-term course and predictors of quality of life (QoL) following acute pulmonary embolism (PE). RESEARCH QUESTION What are the kinetics and determinants of disease-specific and generic health-related QoL 3 and 12 months following an acute PE? STUDY DESIGN AND METHODS The Follow-up after Acute Pulmonary Embolism (FOCUS) study prospectively followed up consecutive adult patients with objectively diagnosed PE. Patients were considered for study who completed the Pulmonary Embolism Quality of Life (PEmb-QoL) questionnaire at predefined visits 3 and 12 months following PE. The course of disease-specific QoL as assessed using the PEmb-QoL and the impact …

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryVisual analogue scalePatient-centered outcomesCritical Care and Intensive Care Medicinemedicine.diseasehumanitiesPulmonary embolismClinical trialQuality of lifeInterquartile rangeInternal medicineMedicineCardiology and Cardiovascular MedicinebusinessCohort studyCardiopulmonary diseaseChest
researchProduct

Longitudinal relationship between B-type natriuretic peptide and anxiety in coronary heart disease patients with depression.

2018

Patients with coronary heart disease (CHD) suffer from physical limitations, but also from psychological distress. Natriuretic peptides may be involved in the neurobiological processes that modulate psychological adaptation, as they are increased in heart disease and seem to have an anxiolytic-like function. Longitudinal data on this association are scarce.To assess the relationship between NT-proBNP and anxiety (Hospital Anxiety and Depression Scale (HADS)), we used secondary data from a multicenter trial from baseline to 24 months. Patients (N = 308, 80.8% male, mean age 60.1 years) had stable CHD and moderate levels of depression (HADS ≥8).Multiple linear regression adjusted for age, sex…

Malemedicine.medical_specialtyHeart diseasemedicine.drug_classDiseaseCoronary Artery DiseaseAnxietyHospital Anxiety and Depression ScaleCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicineMulticenter trialNatriuretic Peptide BrainNatriuretic peptideMedicineHumanscardiovascular diseases030212 general & internal medicineLongitudinal StudiesDepression (differential diagnoses)Depressive Disorderbusiness.industryAnxiety ; Coronary Heart Disease ; Depression ; Natriuretic PeptideMiddle Agedmedicine.diseasePeptide FragmentsPsychotherapyPsychiatry and Mental healthClinical PsychologyAnxietyFemalemedicine.symptombusinesshormones hormone substitutes and hormone antagonists030217 neurology & neurosurgeryJournal of psychosomatic research
researchProduct